workforce news

Bowelbabe Fund Hits £20M: Pharmacy's Role in Cancer Awareness

As Prince William marks the £20 million Bowelbabe Fund milestone, we look at what community pharmacy contributes to cancer screening and early detection.

By PharmSee · · 1 views

The Bowelbabe Fund, established by Dame Deborah James in 2022 to support Cancer Research UK, has reached its £20 million fundraising milestone, with Prince William praising the achievement on 2 April 2026.

The fund supports research into personalised medicine, clinical trials, and immunotherapy. But cancer care does not begin or end in the research laboratory — and community pharmacy has a growing, if often overlooked, role in cancer screening and early detection.

What pharmacies already do

Community pharmacies across England are involved in several cancer-related services and public health campaigns:

Bowel cancer screening kit distribution. The NHS Bowel Cancer Screening Programme sends home testing kits (faecal immunochemical tests, or FIT) to adults aged 56–74, with the programme expanding to include 50–55 year-olds. Community pharmacies can serve as collection and return points in some areas, though this varies by local commissioning arrangements.

Smoking cessation services. Smoking is the single largest preventable cause of cancer in the UK, according to Cancer Research UK. Community pharmacies have long been commissioned to deliver NHS stop-smoking services, including nicotine replacement therapy and behavioural support. PharmSee's analysis of NHSBSA dispensing data shows smoking cessation as one of the tracked pharmacy service categories.

Skin cancer awareness. Some pharmacy chains and local pharmaceutical committees run seasonal campaigns encouraging customers to check moles and skin changes, though formal skin-screening services are not routinely commissioned through community pharmacy.

Palliative care medicines. Community pharmacies designated as palliative care stockists hold specialist medicines for cancer patients in the terminal phase, ensuring that pain relief and symptom management medicines are available locally without hospital attendance.

The workforce behind the counter

Among the 1,380 pharmacy vacancies currently tracked by PharmSee, a small but growing number of NHS roles explicitly reference oncology and cancer services:

According to PharmSee's analysis of 200 NHS Jobs pharmacy listings (a sample representing approximately 39% of the 512 total NHS pharmacy vacancies), specialist roles in cancer services — including titles referencing oncology, chemotherapy, and cancer-related clinical pharmacy — appear in the dataset, though the precise count is small enough that it should be treated as a directional indicator rather than a robust estimate.

Advanced specialist clinical pharmacist roles in areas such as breast cancer and cancer services were listed at salaries of £66,582–£77,368 per annum, according to NHS Jobs listings captured by PharmSee. These are among the highest-paid pharmacy roles in the NHS.

Community pharmacy and public health

The connection between the Bowelbabe Fund's research focus and the community pharmacy network is indirect but important. Research funding produces new treatments; community pharmacies help ensure those treatments reach patients, manage side effects, and support adherence.

With over 13,000 community pharmacies in England — more accessible than GP surgeries or hospitals for many patients — the pharmacy counter is often where cancer awareness campaigns have their most direct public-facing impact.

Pharmacy serviceCancer relevance
Smoking cessationReduces cancer risk (largest preventable cause)
Bowel screening supportEarly detection of colorectal cancer
Palliative care medicinesEnd-of-life symptom management
Pharmacy First consultationsPotential pathway for symptom identification
Vaccination servicesHPV vaccination (cervical cancer prevention)

What the data shows

PharmSee tracks 13,147 community pharmacies across England. These pharmacies collectively dispensed over 5.3 million recorded transactions in the NHSBSA dataset, spanning 35 months of dispensing history.

While cancer-specific dispensing data is not separately identifiable in the NHSBSA records (items are categorised by BNF code rather than by indication), the sheer scale of the pharmacy network's daily patient contact means that every pharmacist and dispenser is a potential touchpoint for cancer awareness.

Explore pharmacy services in your area using PharmSee's pharmacy finder, or compare pharmacy provision across regions on the location analysis tool.

Data: PharmSee NHSBSA pharmacy register (13,147 pharmacies, England). News source: BBC News, 2 April 2026.